Ventilators are in short supply. So are medications for coronavirus patients using them.


Hospitals are running low on pretty much everything they need to fight the COVID-19 pandemic.
Shortages of ventilators to treat severe coronavirus cases and masks to protect health care workers have been widely publicized, prompting companies to switch gears and start producing those needed supplies. But medications necessary for treating patients on ventilators are also in short supply, and it's getting harder and harder to get those prescriptions filled, Stat News reports.
Patients on ventilators are given a mixture of sedatives, anesthetics, painkillers, and muscle relaxants "to help manage patient pain and comfort levels so they can benefit from mechanical ventilation," Stat writes. So as coronavirus cases rose throughout March, there was a 51 percent jump in demand for six commonly used sedatives and anesthetics. But at the same time, the rate at which those prescriptions are filled and given to hospitals dropped from 100 percent to just 63 percent by March 24, per Stat.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Painkillers, including hydromorphone, fentanyl, and morphine, saw a 67 percent increase in demand during March, but their fill rate dropped from 82 percent to 77 percent. And demand for four common neuromuscular blockers rose 39 percent while the fill rate fell to 70 percent, Stat notes.
These shortages have a variety of causes. Major pharmaceutical company Pfizer said it's experiencing manufacturing delays, while some had stopped making those now-necessary drugs altogether. Erin Fox, who tracks drug shortages at the University of Utah Health Care, told Stat it's likely manufacturers haven't been "ramping up production for the surge." Coupled with import and production stoppages from India and China, it's all adding up to a deadly situation. Read more at Stat News.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
An introvert's dream? Flu camps that offer £4,400 to spend two weeks alone
Under The Radar A fortnight in isolation may not be as blissful as it sounds
-
Can Trump put his tariffs on stronger legal footing?
Today's Big Question Appeals court says 'emergency' tariffs are improper
-
Film reviews: The Roses, Splitsville, and Twinless
Feature A happy union devolves into domestic warfare, a couple's open marriage reaps chaos, and an unlikely friendship takes surprising turns
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year